The latest in treatments for incontinence in women.
Hinze
Joyce
J
Junkin
Joan
J
D017677:Age Distribution; D000368:Aged; D001521:Behavior Therapy; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D001672:Biocompatible Materials; D003094:Collagen; D003408:Cresols / Q000627:therapeutic use; D000068736:Duloxetine Hydrochloride; D004599:Electric Stimulation Therapy; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D008333:Mandelic Acids / Q000627:therapeutic use; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D017773:Pelvic Floor; D010570:Pessaries; D010665:Phenylpropanolamine / Q000627:therapeutic use; D015995:Prevalence; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D017678:Sex Distribution; D013876:Thiophenes / Q000627:therapeutic use; D000068737:Tolterodine Tartrate; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000453:epidemiology / Q000628:therapy*; D016741:Urinary Sphincter, Artificial; D016387:Women's Health
D001559:Benzhydryl Compounds; D001672:Biocompatible Materials; D003094:Collagen; D003408:Cresols; D000068736:Duloxetine Hydrochloride; D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes; D000068737:Tolterodine Tartrate; C048470:glutaraldehyde-cross-linked collagen; C005419:oxybutynin